New Commercial Director at RecipharmCobra Biologics

Julian Hanak has been named commercial director at RecipharmCobra Biologics. He will join the management team to build on the company’s growth in provision of manufacturing services for the biotech and biopharmaceutical industry.

Mr. Hanak has held senior positions in both contract service and biotech product development companies. Formerly at Renovo Plc, a biopharmaceutical drug discovery and development company, he gained senior management and commercial experience as senior vice president of Development, where he oversaw CMOs and direction of CMC activities during drug development. He previously worked at RecipharmCobra Biologics’ Keele facility for 11 years progressing from Senior Scientist to Director of Production. Mr. Hanak also held positions at the National Institute for Medical Research, Bio Products Laboratory Ltd and AstraZeneca.
 
Peter Coleman, RecipharmCobra Biologics’s chief executive officer, said, “I am delighted that Julian has decided to join RecipharmCobra Biologics as we look to strengthen our team’s depth of experience to expand our clinical production offering and to reach our goal as a leading commercial supplier for our customers. We all look forward to working with Julian to achieve these goals.”